Acorda Therapeutics Inc (NASDAQ:ACOR)

26.10
Delayed Data
As of 4:00pm ET
 +0.80 / +3.16%
Today’s Change
13.60
Today|||52-Week Range
33.00
+21.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues401.5M492.7M519.6M588.3M
 
 
 
 
 
Cost of Goods Sold72.1M77.9M86.5M135.7M
 
 
 
 
 
Depreciation And Amortization8.5M15.0M21.6M--
 
 
 
 
 
Operating ExpensesGross Income320.9M399.7M411.5M452.6M
 
 
 
 
 
General Expenses268.5M354.8M421.3M347.4M
 
 
 
 
 
Research And Development73.5M149.2M203.4M166.1M
 
 
 
 
 
Total Operating Expenses349.1M447.8M529.4M483.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income52.4M44.9M-9.8M105.2M
 
 
 
 
 
Extraordinary Credit236.0K0.00----
 
 
Extraordinary Charge-16.4M-10.9M-26.2M-338.0M
 
 
 
 
 
Interest Expense On Debt9.3M15.5M16.5M--
 
 
 
 
Other Expenses379.0K411.0K9.9M-19.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.0M19.4M-42.3M-251.9M
 
 
 
 
 
Income Taxes-10.3M-8.3M-6.7M-28.5M
 
 
 
 
 
Minority Interest0.000.00-985.0K0.00
 
 
Net Income17.7M11.1M-34.6M-223.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M42.2M45.3M46.0M
 
 
 
 
 
Shares To Calculate EPS Diluted42.5M43.6M45.3M46.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.42$0.25-$0.76-$4.86
 
 
 
 
 
EPS Diluted$0.42$0.25-$0.76-$4.86